Methods for Producing T lymphocytes in vitro from Stem Cells
Methods for Producing T lymphocytes in vitro from Stem Cells
批准号:
BB/H023690/1
负责人:
Martin Turner
金额:
$13.48万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2010
资助国家:
英国
项目状态:
已结题
起止时间:
2010 至 --
中文摘要
T淋巴细胞是一种白色血细胞,对免疫系统的功能至关重要。这些细胞的异常功能与免疫缺陷(例如AIDS)或自身免疫(例如I型糖尿病、类风湿性关节炎)相关。T淋巴细胞来源于造血干细胞,并在胸腺中完成其成熟,胸腺是一个位于心脏附近的器官,它已经进化到专门提供促进T细胞发育的环境。造血干细胞成熟为T淋巴细胞时所经历的发育阶段已经得到了相对良好的表征。这使得能够识别细胞必须通过的关键监管检查点,以便进一步发展。其中一个检查点被称为β选择。为了通过这个检查点,细胞必须产生特定的信号,引起基因表达的变化,并允许细胞分裂和分化。T细胞发育的体外模型依赖于来源于支持基质细胞的辅助因子,其中Notch-1配体是最好理解的。然而,Notch-1配体不足以在辅助细胞不存在的情况下允许T细胞发育,表明需要由基质细胞产生的额外因子。我们已经鉴定了趋化因子CXCL 12作为β-选择过程中的辅因子,这使我们能够创建允许β-选择的无辅助细胞培养系统。我们现在建议检查层粘连蛋白和Wnt等其他基质衍生成分在无细胞系统中的作用。我们还建议测试我们对胸腺细胞发育的认识是否允许T细胞从干细胞生长而不需要基质辅助细胞。这将提供一个更简单的系统来评估分化的分子过程。此外,它可以允许T细胞的扩增,用于再生医学领域中基于细胞的治疗。
英文摘要
T lymphocytes, so-called because they develop in the thymus, are a type of white blood cell crucial for the function of the immune system. Aberrant function of these cells is associated with immunodeficiency (e.g. AIDS) or autoimmunity (e.g. type I diabetes, rheumatoid arthritis). T lymphocytes are derived from blood stem cells and complete their maturation in the thymus, an organ located near the heart that has evolved specifically to provide an environment that promotes T cell development. The developmental stages haematopoietic stem cells pass through as they mature into T lymphocytes have been relatively well-characterised. This has allowed the identification of key regulatory checkpoints that cells must pass through in order to develop further. One of these checkpoints is called beta-selection. In order to pass through this checkpoint cells must generate specific signals which bring about changes in gene expression and allows the cells to divide and differentiate. In vitro models of T cell development rely on accessory factors derived from supporting stromal cells of which Notch-1 ligands are the best understood. However Notch-1 ligand is insufficient to allow T cell development in the absence of accessory cells indicating additional factors produced by the stromal cells are required. We have identified the chemokine CXCL12 as a co-factor in the process of beta-selection and this has enabled us to create an accessory cell free culture system which is permissive for beta-selection. We now propose to examine the effect of additional stromal derived components such as laminin and Wnt for their effect in a cell-free system. We also propose to test whether our insight into the development of thymocytes will permit the growth of T cells from stem cells without the need for stromal accessory cells. This will provide a simpler system to evaluate the molecular processes of differentiation. Furthermore, it may permit the expansion of T cells for cell-based therapy in the area of regenerative medicine.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1371/journal.pone.0058501
发表时间:
2013
期刊:
PloS one
影响因子:
3.7
作者:
[Schroeder JH, Bell LS, Janas ML, Turner M]
通讯作者:
Turner M
Mechanisms restraining the accumulation of antibody secreting cells
-
批准号:BB/W015242/1
-
项目类别:Research Grant
-
资助金额:$95.83万
-
财政年份:2023
-
负责人:Martin Turner
-
依托单位:
PTBP proteins in T cell activation: Cellular and molecular mechanisms of action
-
批准号:BB/P01898X/1
-
项目类别:Research Grant
-
资助金额:$95.79万
-
财政年份:2017
-
负责人:Martin Turner
-
依托单位:
Testing the Mechanism of T lymphocyte selection in the thymus mediated by the zfp36 family of RNA binding proteins
-
批准号:MR/N010434/1
-
项目类别:Research Grant
-
资助金额:$47.72万
-
财政年份:2016
-
负责人:Martin Turner
-
依托单位:
Dissecting the molecular mechanisms of PI3K in Extra-Follicular Helper and Regulatory T cell differentiation
-
批准号:BB/M021343/1
-
项目类别:Research Grant
-
资助金额:$49.74万
-
财政年份:2015
-
负责人:Martin Turner
-
依托单位:
Developing The Oxford Study for Biomarkers in Motor Neuron Disease (BioMOx): Capturing pre-symptomatic events and advancing clinical translation
-
批准号:MR/K01014X/1
-
项目类别:Fellowship
-
资助金额:$203.88万
-
财政年份:2013
-
负责人:Martin Turner
-
依托单位:
transgenic expression of UPRT as a novel tool for tagging RNA in specific tissues of the mouse
-
批准号:BB/K013424/1
-
项目类别:Research Grant
-
资助金额:$13.98万
-
财政年份:2013
-
负责人:Martin Turner
-
依托单位:
Sampling, biomarker OPtimization and Harmonization In ALS (SOPHIA)
-
批准号:MR/K000780/1
-
项目类别:Research Grant
-
资助金额:$9.31万
-
财政年份:2012
-
负责人:Martin Turner
-
依托单位:
Cell-intrinsic roles of P110delta in primary and memory antibody responses
-
批准号:BB/I01246X/1
-
项目类别:Research Grant
-
资助金额:$56.62万
-
财政年份:2012
-
负责人:Martin Turner
-
依托单位:
RNA processing mechanisms control lymphocyte development and activation
-
批准号:BB/J00152X/1
-
项目类别:Research Grant
-
资助金额:$367.89万
-
财政年份:2012
-
负责人:Martin Turner
-
依托单位:
PI3Kdelta regulation of influenza virus morbidity
-
批准号:G1001068/1
-
项目类别:Research Grant
-
资助金额:$63.13万
-
财政年份:2011
-
负责人:Martin Turner
-
依托单位:
Genetic analysis of the role of the PI3K signalling in humoral immunity
-
批准号:BB/E021638/1
-
项目类别:Research Grant
-
资助金额:$50.46万
-
财政年份:2008
-
负责人:Martin Turner
-
依托单位:
Biomarkers in motor neuron disease - a longitudinal translational neuroimaging and CSF study
-
批准号:G0701923/1
-
项目类别:Fellowship
-
资助金额:$130.89万
-
财政年份:2008
-
负责人:Martin Turner
-
依托单位:
PI3K signalling and T lymphocyte development
-
批准号:BB/F02066X/1
-
项目类别:Research Grant
-
资助金额:$67.27万
-
财政年份:2008
-
负责人:Martin Turner
-
依托单位:
Molecular mechanisms of B Lymphocyte differentiation and activation
-
批准号:G0601618/1
-
项目类别:Fellowship
-
资助金额:$179.08万
-
财政年份:2007
-
负责人:Martin Turner
-
依托单位:
海外基金